Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravaginal misoprostol to reduce blood loss during myomectomy
IRCT2013100714927N1Phase 2Completed
- Sponsor
- Vice chancellor for research , Tehran University of Medical Sciences
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of misoprostol in Fibromyoma (LM), sponsored by Vice chancellor for research , Tehran University of Medical Sciences. Primary endpoint: Intraoperative blood loss. Started Oct 2013; status: completed.
02
Drugs
misoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT2013100714927N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013100714927N1.